Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-23-156711
Filing Date
2023-05-30
Accepted
2023-05-30 17:16:10
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 d508876d424b5.htm 424B5 7677
2 GRAPHIC g508876g01a10.jpg GRAPHIC 35768
  Complete submission text file 0001193125-23-156711.txt   52113
Mailing Address 101 HARTWELL AVENUE LEXINGTON MA 02421
Business Address 101 HARTWELL AVENUE LEXINGTON MA 02421 781-457-1200
T2 Biosystems, Inc. (Filer) CIK: 0001492674 (see all company filings)

EIN.: 204827488 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254918 | Film No.: 23977723
SIC: 3841 Surgical & Medical Instruments & Apparatus